Balance Sheet Breakdown: ReShape Lifesciences Inc. (RSLS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $0.23 in the prior trading day, ReShape Lifesciences Inc. (NASDAQ: RSLS) closed at $0.22, down -3.93%. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 1.21 million shares were traded. RSLS stock price reached its highest trading level at $0.2306 during the session, while it also had its lowest trading level at $0.2186.


Our goal is to gain a better understanding of RSLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 2.24. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 25 ’23 when STANKOVICH THOMAS sold 131 shares for $0.27 per share. The transaction valued at 35 led to the insider holds 22,949 shares of the business.

STANKOVICH THOMAS sold 39 shares of RSLS for $36 on Oct 11 ’23. The Chief Financial Officer now owns 23,080 shares after completing the transaction at $0.93 per share. On Sep 01 ’23, another insider, STANKOVICH THOMAS, who serves as the Chief Financial Officer of the company, sold 118 shares for $0.89 each. As a result, the insider received 105 and left with 23,119 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RSLS now has a Market Capitalization of 5277847 and an Enterprise Value of 3137845. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 0.376 whereas that against EBITDA is -0.283.

Stock Price History:

Over the past 52 weeks, RSLS has reached a high of $2.55, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 22.32%, while the 200-Day Moving Average is calculated to be -24.83%.

Shares Statistics:

The stock has traded on average 5.26M shares per day over the past 3-months and 30455350 shares per day over the last 10 days, according to various share statistics. A total of 23.46M shares are outstanding, with a floating share count of 20.81M. Insiders hold about 11.27% of the company’s shares, while institutions hold 1.25% stake in the company. Shares short for RSLS as of 1715731200 were 310621 with a Short Ratio of 0.06, compared to 1713139200 on 487784. Therefore, it implies a Short% of Shares Outstanding of 310621 and a Short% of Float of 1.48.

Most Popular